# Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1

> **NCT07122258** · NA · RECRUITING · sponsor: **Tau Medical Australia Pty Ltd** · enrollment: 7 (estimated)

## Conditions studied

- NSCLC (Non-small Cell Lung Cancer)

## Interventions

- **DEVICE:** CAROL NSCLC treatment Device

## Key facts

- **NCT ID:** NCT07122258
- **Lead sponsor:** Tau Medical Australia Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07122258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07122258, "Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT07122258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*